1887

Abstract

Human cytomegalvirus (HCMV) ORF UL73 is a polymorphic locus, encoding the viral glycoprotein gpUL73-gN, a component of the gC-II envelope complex. The previously identified gN genomic variants, denoted gN-1, gN-2, gN-3 and gN-4, were further investigated in this work by analysing a large panel of HCMV clinical isolates collected from all over the world (223 samples). Sequencing and phylogenetic analysis confirmed the existence of the four gN genotypes, but also allowed the identification of a novel subgroup belonging to the gN-3 genotype, which was designated gN-3b. The number of non-synonymous (d) and synonymous (d) nucleotide substitutions and their ratio (d/d) were estimated among the gN genotypes to evaluate the possibility of positive selection. Results showed that the four variants evolved by neutral (random) selection, but that the gN-3 and gN-4 genotypes are maintained by positive selective pressure. The 223 HCMV clinical isolates were subdivided according to their geographical origin, and four main regions of gN prevalence were identified: Europe, China, Australia and Northern America. The gN variants were found to be widespread and represented within the regions analysed without any significant difference, and no new genotype was detected. Finally, for clinical and epidemiological purposes, a rapid and low-cost method for genetic grouping of the HCMV clinical isolates was developed based on the RFLP revealed by I, I and I digestion of the PCR-amplified UL73 sequence. This technique enabled us to distinguish all four gN genomic variants and also their subtypes.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.18704-0
2003-03-01
2020-04-03
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/3/vir840647.html?itemId=/content/journal/jgv/10.1099/vir.0.18704-0&mimeType=html&fmt=ahah

References

  1. Britt W. J., Auger D.. 1985; Identification of a 65 000 dalton virion envelope protein of human cytomegalovirus. Virus Res4:31–36
    [Google Scholar]
  2. Brown J. M., Kaneshima H., Mocarski E. S.. 1995; Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. J Infect Dis171:1599–1603
    [Google Scholar]
  3. Chern K. H., Chandler D. B., Martin D. F., Kuppermann B. D., Wolitz R. A., Margolis T. P.. 1998; Glycoprotein B subtyping of cytomegalovirus (CMV) in the vitreous of patients with AIDS and CMV retinitis. J Infect Dis178:1149–1152
    [Google Scholar]
  4. Chou S.. 1992a; Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus. J Infect Dis166:604–607
    [Google Scholar]
  5. Chou S.. 1992b; Comparative analysis of sequence variation in gp116 and gp55 components of glycoprotein B of human cytomegalovirus. Virology188:388–390
    [Google Scholar]
  6. Chou S., Dennison K. M.. 1991; Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis163:1229–1234
    [Google Scholar]
  7. Dal Monte P., Pignatelli S., Mach M., Landini M. P.. 2001; The product of human cytomegalovirus (HCMV) UL73 is a new polymorphic structural glycoprotein (gpUL73. J Hum Virol4:26–33
    [Google Scholar]
  8. Eddy S. R.. 1995; Multiple alignment using hidden Markov models. Proc Int Conf Intell Syst Mol Biol3:114–120
    [Google Scholar]
  9. Endo T., Ikeo K., Gojobori T.. 1996; Large-scale search for genes on which positive selection may operate. Mol Biol Evol13:685–690
    [Google Scholar]
  10. Fries B. C., Chou S., Boeckh M., Torok-Storb B.. 1994; Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis169:769–774
    [Google Scholar]
  11. Gilbert C., Handfield J., Tome E., Lalonde R., Bergeron M. G., Boivin G.. 1999; Human cytomegalovirus glycoprotein gB genotypes in blood of AIDS patients: lack of association with either the viral DNA load in leukocytes or presence of retinitis. J Med Virol59:98–103
    [Google Scholar]
  12. Gojobori T., Moriyama E. N., Kimura M.. 1990; Molecular clock of viral evolution and the neutral theory. Proc Natl Acad Sci U S A87:10015–10018
    [Google Scholar]
  13. Gojobori T., Yamaguchi Y., Ikeo K., Mizokami M.. 1994; Evolution of pathogenic viruses with special reference to the rates of synonymous and non-synonymous substitutions. Jpn J Genet69:481–488
    [Google Scholar]
  14. Hein J., Stovlbaek J.. 1996; Combined DNA and protein alignment. Methods Enzymol266:402–418
    [Google Scholar]
  15. Huang X.. 1994; On global sequence alignment. Comput Appl Biosci10:227–235
    [Google Scholar]
  16. Ina Y., Gojobori T.. 1994; Statistical analysis of nucleotide sequences of the hemagglutinin genes of human influenza A viruses. Proc Natl Acad Sci U S A91:8388–8392
    [Google Scholar]
  17. Kari B., Gehrz R.. 1990; Analysis of human antibody responses to human cytomegalovirus envelope glycoproteins found in two families of disulfide linked glycoprotein complexes designated gC-I and gC-II. Arch Virol114:213–228
    [Google Scholar]
  18. Kimura M.. 1983; The Neutral Theory of Molecular Evolution London: Cambridge University Press;
    [Google Scholar]
  19. Klein M., Schoppel K., Amvrossiadis N., Mach M.. 1999; Strain-specific neutralization of human cytomegalovirus isolates by human sera. J Virol73:878–886
    [Google Scholar]
  20. Mach M., Kropff B., Dal Monte P., Britt W. J.. 2000; Complex formation of human cytomegalovirus glycoprotein M (gpUL100) and glycoprotein N (gpUL73). J Virol74:11881–11892
    [Google Scholar]
  21. Meyer-Konig U., Vogelberg C., Bongarts A.. 7 other authors 1998a; Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J Med Virol55:75–81
    [Google Scholar]
  22. Meyer-Konig U., Haberland M., von Laer D., Haller O., Hufert F. T.. 1998b; Intragenic variability of human cytomegalovirus glycoprotein B in clinical strains. J Infect Dis177:1162–1169
    [Google Scholar]
  23. Navarro D., Paz P., Tugizov Z., Topp K., La Vail J., Pereira L.. 1993; Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell and fusion of infected cells. Virology197:143–158
    [Google Scholar]
  24. Nei M., Gojobori T.. 1986; Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol3:418–426
    [Google Scholar]
  25. Paterson D. A., Dyer A. P., Milne R. S., Sevilla-Reyes E., Gompels U. A.. 2002; A role for human cytomegalovirus glycoprotein O (gO) in cell fusion and a new hypervariable locus. Virology239:281–294
    [Google Scholar]
  26. Pignatelli S., Dal Monte P., Landini M. P.. 2001; gpUL73(gN) genomic variants of human cytomegalovirus (HCMV) isolates are clustered into four distinct genotypes. J Gen Virol82:2777–2784
    [Google Scholar]
  27. Pignatelli S., Dal Monte P., Zini N., Valmori A., Maraldi N. M., Landini M. P.. 2002; Intracellular and intraviral localization of gpUL73(gN), a recently discovered structural glycoprotein of human cytomegalovirus. Arch Virol147:1247–1256
    [Google Scholar]
  28. Pignatelli S., Rossini G., Dal Monte P., Gatto M. R., Landini M. P.. 2003a; Human cytomegalovirus glycoprotein N (gN) genotypes in AIDS patients. AIDS (in Press)
    [Google Scholar]
  29. Pignatelli S., Dal Monte P., Rossini G., Lazzarotto T., Gatto M. R., Landini M. P.. 2003b; Intrauterine cytomegalovirus infection and glycoprotein N (gN) genotypes. J Clin Virol (in Press)
    [Google Scholar]
  30. Plotkin S. A.. 2001; Vaccination against cytomegalovirus. Arch VirolS17:121–134
    [Google Scholar]
  31. Rasmussen L.. 2001; Clinical isolates of human cytomegalovirus are polymorphic for the gC-III envelope glycoprotein complex. In 8th International Cytomegalovirus Conference. Asilomar, Monterey, CA, USA. May 20–25; abstract. p. 38
    [Google Scholar]
  32. Rasmussen L., Hong C., Zipeto D., Morris S., Sherman D., Wolitz R., Dowling A., Warford A., Merigan T. C.. 1997; Cytomeglovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J Infect Dis175:179–184
    [Google Scholar]
  33. Sasaki A.. 1994; Evolution of antigen drift/switching: continuously evading pathogens. J Theor Biol168:291–308
    [Google Scholar]
  34. Shepp D. H., Match M. E., Lipson S. M., Pergolizzi R. G.. 1998; A fifth human cytomegalovirus glycoprotein B genotype. Res Virol149:109–114
    [Google Scholar]
  35. Trincado D. E., Scott G. M., White P. A., Hunt C., Rasmussen L., Rawlinson W. D.. 2000; Human cytomegalovirus strains associated with congenital and perinatal infections. J Med Virol61:481–487
    [Google Scholar]
  36. Van der Bij W., Torensma R., van Son W. J., Anema J., Shirm J., Tegzess A. M., The T. H.. 1988; Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J Med Virol25:179–188
    [Google Scholar]
  37. Yamaguchi-Kabata Y., Gojobori T.. 2000; Reevaluation of amino acid variability of the human immunodeficiency virus type 1 gp120 envelope glycoprotein and prediction of new discontinuous epitopes. J Virol74:4335–4350
    [Google Scholar]
  38. Zhang L., Diaz R. S., Ho D. D., Mosley J. V., Busch M. P., Mayer A.. 1997; Host-specific driving force in human immunodeficiency virus type 1 evolution in vivo . J Virol71:2555–2561
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.18704-0
Loading
/content/journal/jgv/10.1099/vir.0.18704-0
Loading

Data & Media loading...

Most cited this month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error